Max Healthcare Institute Limited (MAXHEALTH) — Financial Results | 30 January 2025(4 announcements)

Max Healthcare Institute reported consolidated net profit of ₹87.22 crores for Q3 FY25, up 32% from ₹65.98 crores in Q3 FY24, driven by strong revenue growth and improved margins. The company highlighted robust operational performance and maintained its growth trajectory despite macroeconomic headwinds.

Max Healthcare Institute reported Q3 FY25 revenue of ₹2,381 crores, up 34% YoY, with Operating EBITDA at ₹622 crores, up 32% YoY, and PAT before exceptional items at ₹390 crores, up 15% YoY. The company expanded capacity with a new 500-bed hospital in Thane and acquired Jaypee Healthcare Limited, while occupancy rose to 75% and EBITDA per bed reached ₹73.0 lakhs.

Max Healthcare Institute reported a 69.9% YoY jump in Q3 profit to ₹138.24 crores on revenue of ₹78.94 crores, driven by strategic acquisitions and hospital expansions. The company secured ₹1,200 crores in new financing for hospital development, including a ₹500 crore Axis Bank term loan and ₹200 crore loan to Eqova Healthcare. Lease agreements in Zirakpur and Thane will add 400+ and 500+ beds respectively by 2028, leveraging existing brand strength across three states.

Max Healthcare Institute reported revenue of ₹2,00,490 lakhs for Q3 FY2024, up 32% YoY from ₹1,51,911 lakhs, with net profit reaching ₹52,368 lakhs (+69.9% YoY). The quarter showed strong operational growth driven by revenue expansion and improved profitability, though total expenses rose moderately to ₹1,48,017 lakhs. Key developments include strategic acquisitions in healthcare and new hospital lease agreements announced in the filing.